General Federal Contracts — February 07, 2026

Three contracts worth $1.27B (ERAM aviation to 2041, NCI biomed FY26-27, GSA engineering to 2027) add long-term stability with $734M outlayed.

Brasfield & Gorrie (2x, $382M GSA ports/courthouses to 2029), HC Beck ($221M CDC), Stronghold ($217M NPS water) signal border/parks/health facility upgrades.

Remote Medicine ($484M USAID HIV kits to 2026), Kratos ($338M GSA SBIR defense), Synergy ($273M USDA IT), others highlight validated capabilities in health/IT/remediation.

HII ($493M to 2030), Kratos, Leidos, Brasfield awards via FAS/FEDSIM signal scalable federal services demand.

Firm fixed price structures across 60% of contracts ($2.6B, e.g., construction/remediation) expose to cost overruns amid long periods (avg. 5+ yrs).

Subaward dependencies in 80% of contracts (e.g., $73M Leidos aviation, $275M Kratos, $82M Leidos eng) total $700M+ risking delays.

Low/no outlays in new awards (e.g., HII $0, Brasfield $0, Leidos Biomed $24M) signal funding delays amid FY26 budget uncertainty.

$1.2B+ in unexercised options (e.g., Leidos $6.8B ERAM ceiling, HII $860M, Remote Med $77M) across 70% of contracts.

Extensions to 2027-2041 in 80% of deals (e.g., Leidos aviation 2041, HII 2030) enable follow-ons in IT/health/defense.

Small biz scale-ups post-set-asides (e.g., North Wind $64M options, Alvarez $101M) in remediation/IT for commercialization.

47% of value ($2B) in NAICS 541xxx (e.g., Leidos ERAM, Synergy USDA, Salient DHS) with GSA/NIH focus to 2027+.

25% ($1.1B) in NAICS 236/237 (ports, parks, CDC bldgs) via GSA/DOI to 2029 amid border/parks priorities.

20% ($850M) in biomed/HIV kits/remediation (Leidos NCI, Remote Med USAID, North Wind DOE) to 2027.

{"entity"=>"Leidos Holdings", "reason"=>"Largest exposure at $1.27B (23%), multi-decade ERAM to 2041 anchors backlog.", "trigger"=>"ERAM option exercises >$6B ceiling or NCI FY27 ramp"}

{"entity"=>"Brasfield & Gorrie", "reason"=>"$382M (9%) in GSA construction signals infra pipeline expansion.", "trigger"=>"Brownsville port funding release or Savannah extension"}

{"entity"=>"Small Disadvantaged Businesses (e.g., Remote Medicine, North Wind)", "reason"=>"$1.7B wins validate niches; options/follow-ons could double value.", "trigger"=>"Set-aside recompetes or Phase III commercialization"}

{"entity"=>"HII Mission Technologies", "reason"=>"$493M GSA with $860M options and $0 outlay flags near-term catalyst.", "trigger"=>"Initial outlays or 2030 extension award"}